Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 28:47:93.
doi: 10.11604/pamj.2024.47.93.32594. eCollection 2024.

Essential thrombocythemia: nutritional management in weight loss and malnutrition

Isabela de Souza da Costa Brum  1   2 , Julia Goncalves  1   3 , Mariana Zanchetta  1 , Bruna Xerém  1 , Renata Lanziani  1 , Marcia Haiut  1 , Masato Hada  4 , Alexandre Gustavo Apa  5 , Karen Cordovil  1   3
Affiliations

Essential thrombocythemia: nutritional management in weight loss and malnutrition

Isabela de Souza da Costa Brum et al. Pan Afr Med J. .

Abstract

Essential thrombocythemia is the category of myeloproliferative syndromes, generally characterized by a group of clonal stem cell diseases that present a disturbance in the growth of one or more sets of hematopoietic cells. All long clinical treatment, patients may experience gastrointestinal disorders and other metabolic processes that can lead to weight loss and malnutrition. Cytokine is involved in the control of appetite, digestive, and metabolic processes in the body, it can be assumed that increased stimulation could impair the control of these processes leading to loss of body mass. Effective and systematic nutritional intervention is required to ensure patient compliance with treatment and improved nutritional status.

Keywords: Essential thrombocythemia; body mass loss; cytokine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Accurso V, Santoro M, Mancuso S, Napolitano M, Carlisi M, Mattana M, et al. The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep. Clin Med Insights Blood Disord. 2020 Dec 28;13:2634853520978210. - PMC - PubMed
    1. Moulard O, Mehta J, Fryzek J, Olivares R, Iqbal U, Mesa RA. Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union. Eur J Haematol. 2014 Apr;92(4):289–97. - PubMed
    1. National Cancer Registry Ekurhuleni population-based cancer registry annual 2018 report. South Africa. 2021.
    1. Yassin MA, Taher A, Mathews V, Hou HA, Shamsi T, Tuglular T, et al. Myeloproliferative neoplasms in Asia, including Middle East, Turkey, and Algeria: epidemiological indices and treatment practice patterns from the multinational, multicenter, observational MERGE registry. Blood. 2018 Nov 29;132:5461.
    1. Seguro FS, Teixeira LLC, da Rosa LI, da Silva WF, Nardinelli L, Bendit I, et al. Risk factors and incidence of thrombosis in a Brazilian cohort of patients with Philadelphia-negative myeloproliferative neoplasms, neoplasms. J Thromb Thrombolysis. 2020 May;49(4):667–672. - PubMed